The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in […]
| Inventor | Institute |
|---|---|
| Bernhard Singer | LeukoCom |
| Cat. #: | 160700 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Microbiology |
| Application: | ELISA ; IHC ; Fn ; WB |
| Target: | SARS CoV-2 Spike |
| Reactivity: | Virus |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Immunogen: | Recombinant SAR-CoV-2 spike-human Fc protein |
| Myeloma used: | NS1/0 |
| Target background: | The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.